1. Home
  2. FUNC vs MDWD Comparison

FUNC vs MDWD Comparison

Compare FUNC & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First United Corporation

FUNC

First United Corporation

N/A

Current Price

$38.62

Market Cap

247.8M

Sector

Finance

ML Signal

N/A

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$17.65

Market Cap

230.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUNC
MDWD
Founded
1900
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
247.8M
230.7M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
FUNC
MDWD
Price
$38.62
$17.65
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$37.50
AVG Volume (30 Days)
16.7K
67.9K
Earning Date
10-20-2025
11-20-2025
Dividend Yield
2.72%
N/A
EPS Growth
56.67
N/A
EPS
3.84
N/A
Revenue
$83,662,000.00
$20,932,000.00
Revenue This Year
$16.22
$15.89
Revenue Next Year
$7.42
$25.33
P/E Ratio
$9.94
N/A
Revenue Growth
17.79
6.15
52 Week Low
$24.66
$14.14
52 Week High
$42.50
$22.51

Technical Indicators

Market Signals
Indicator
FUNC
MDWD
Relative Strength Index (RSI) 66.28 47.68
Support Level $37.74 $17.10
Resistance Level $38.69 $18.40
Average True Range (ATR) 0.73 0.73
MACD 0.26 -0.04
Stochastic Oscillator 95.72 46.67

Price Performance

Historical Comparison
FUNC
MDWD

About FUNC First United Corporation

First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: